New Products

Beauty market research company NPD Group recently reported that prestige gift sets were once again on the rise within U.S. department stores.


While all prestige gift sets saw double-digit gains, the greatest lift was reported in makeup gift sets. Between January and October 2012, total makeup gift sets rose 26% to $116 million compared with the January to 
October 2011 period.


Total skin care gift sets increased 23% compared with the year-ago period to reach $276 million.


Total sales of fragrance gift sets climbed 10% to $479 million versus 
last year.


Mounting pressure to regulate energy drinks could hamper growth in a category that has been on an upward trajectory for years. But sales of energy drinks have so far been immune to controversy. Mintel forecasts that sales of the products could double from 2011 to 2016. In 2012, Mintel estimates dollar sales for the category will total $9.4 billion, an increase of nearly 11% over 2011 sales. New line extensions, like Red Bull’s Editions, will continue to drive the category.

PITTSBURGH — The Food and Drug Administration approved a new generic drug made by Mylan for urinary disorders, the company said Thursday.

Mylan announced the approval and launch of tolterodine tartrate tablets in the 1-mg and 2-mg strengths. The drug is a generic version of Detrol, made by Pharmacia and Upjohn, now owned by Pfizer.

Used to treat overactive bladder, tolterodine tartrate tablets had sales of about $61.5 million during the 12-month period ended in September, according to IMS Health.

The greeting card category is shifting. Category giants American Greetings and Hallmark face the threat of competition from e-cards and are challenged by increased segmentation of the card category. Hallmark estimates that over the past decade, the number of greeting cards sold in the United States has dropped from 6 billion to 5 billion annually.


The Greeting Card Association reports that while greeting card unit sales have fluctuated over the past several years, the industry continues to generate annual revenues of $7 billion to $8 billion.


Watson to change brand in 2013
PARSIPPANY, N.J. — Watson Pharmaceuticals is changing its name to Actavis following its acquisition of the Swiss drug maker, Watson said. Watson, whose $5.6 billion acquisition of Actavis received approval from the Federal Trade Commission in October, said it would adopt the new name starting in 2013, with plans to start a multi-year rebranding campaign and trade under a new symbol on the New York Stock Exchange.


MINNEAPOLIS — Novelty gift company 30 Watt introduced its latest prank gift for the outlet-challenged. Billed as a “solution” for hard-to-reach electrical devices, Connect-A-Cord is actually 50 1-ft. sections of extension cord.


The gag gift’s packaging boasts that it “comes with an optional contractor case for tangle-free storage,” but when the recipient opens up the Prank Pack, they will discover the bright yellow flaps inside reading “Prank You!” 


While the term homeopathy may remain as foreign to the American consumer as allopathy, as a relative “class” within each of the respective categories where homeopathic remedies exist, more and more shoppers are placing those homeopathic products in their baskets.

NORTHRIDGE, Calif. — Pharmavite’s recent launch of its Voots Veggie-Fruit Tarts may once and for all put to rest the dinner-table drama of enticing a young child to “eat their veggies.” Voots is a chewable supplement packed with a blend of 11 real fruits and vegetables. What’s more, Mom can pack that veggie-punch into her child’s lunchbox with the Voots single-serve packets. It’s a differentiated product launch in a still-growing category. Sales of vitamins are up 8.3%, to $9.1 billion, for the 52 weeks ended Sept. 29, according 
to Nielsen.